Ando, Apigyn P.
HRN: 07-94-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2022
CEFUROXIME 750MG (VIAL)
04/28/2022
04/29/2022
IV
3 Doses
Q8
S/P Repeat CS With Bilateral Tubal Ligation
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Increase Dose To 1.5g
Overall appropriateness: No Increase Dose To 1.5 G